Biotech & Health
Roche Acquires PathAI, Forging an AI-Powered Future for Medical Diagnostics
Roche has acquired PathAI for $750 million, integrating the AI-focused digital pathology company into its diagnostics division. This strategic move aims to accelerate the adoption of AI-driven tools in medical diagnostics and advance precision medicine.
Juliana Campos·May 18, 2026
